ETHERNA IMMUNOTHERAPIES

etherna-immunotherapies-logo

eTheRNA immunotherapies' mission is to help patients to overcome certain cancers and infectious diseases by developing novel immunotherapies that target the fundamental role of dendritic cells in the human immune system. eTheRNAโ€™s proprietary mRNA-based TriMix technology boosts dendritic cells leading to a more comprehensive, sustainable and safer enhancement of the patientโ€™s immune system than any other similar approach investigated until now.

#SimilarOrganizations #People #Financial #Website #More

ETHERNA IMMUNOTHERAPIES

Social Links:

Industry:
Biotechnology Health Care Medical Device Therapeutics

Founded:
2013-01-01

Address:
Jette, Brussels Hoofdstedelijk Gewest, Belgium

Country:
Belgium

Website Url:
http://www.etherna.be

Total Employee:
11+

Status:
Active

Contact:
+32 3 369 17 40

Total Funding:
111.78 M USD

Technology used in webpage:
LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Nginx Google Maps JsDelivr Cloudflare JS CDN JS ShareThis


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.


Current Advisors List

marijn-dekkers_image

Marijn Dekkers Board Member @ eTheRNA immunotherapies
Board_member

kenneth-chien_image

Kenneth Chien Board Member @ eTheRNA immunotherapies
Board_member

Current Employees Featured

sonja-van-meirvenne_image

Sonja Van Meirvenne
Sonja Van Meirvenne Quality Assurance & Regulatory Affairs @ eTheRNA immunotherapies
Quality Assurance & Regulatory Affairs

steven-powell_image

Steven Powell
Steven Powell CEO @ eTheRNA immunotherapies
CEO
2018-11-01

dirk-reyn_image

Dirk Reyn
Dirk Reyn CEO @ eTheRNA immunotherapies
CEO

luc-lammens_image

Luc Lammens
Luc Lammens Finance @ eTheRNA immunotherapies
Finance

kris-thielemans_image

Kris Thielemans
Kris Thielemans Founder and Chief Scientific Officer @ eTheRNA immunotherapies
Founder and Chief Scientific Officer

Founder


kris-thielemans_image

Kris Thielemans

Investors List

fund_image

Fund+

Fund+ investment in Series B - eTheRNA immunotherapies

novalis-lifesciences_image

Novalis LifeSciences

Novalis LifeSciences investment in Series B - eTheRNA immunotherapies

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series B - eTheRNA immunotherapies

omega-funds_image

Omega Funds

Omega Funds investment in Series B - eTheRNA immunotherapies

grand-pharma_image

Grand Pharma

Grand Pharma investment in Series B - eTheRNA immunotherapies

kenneth-chien_image

Kenneth Chien

Kenneth Chien investment in Series B - eTheRNA immunotherapies

pmv-eu_image

PMV

PMV investment in Series B - eTheRNA immunotherapies

european-commission_image

European Commission

European Commission investment in Grant - eTheRNA immunotherapies

novalis-lifesciences_image

Novalis LifeSciences

Novalis LifeSciences investment in Series B - eTheRNA immunotherapies

bnp-paribas-private-equity_image

BNP Paribas Private Equity

BNP Paribas Private Equity investment in Series B - eTheRNA immunotherapies

Official Site Inspections

http://www.etherna.be Semrush global rank: 4.87 M Semrush visits lastest month: 1.81 K

  • Host name: 199.60.103.182
  • IP address: 199.60.103.182
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "eTheRNA immunotherapies" on Search Engine